{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:16:13Z","timestamp":1769282173602,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T00:00:00Z","timestamp":1235520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1245\/s10434-009-0382-z","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T14:43:22Z","timestamp":1235486602000},"page":"1397-1402","source":"Crossref","is-referenced-by-count":39,"title":["A Preliminary Study on the Postoperative Survival of Patients Given Aspirin After Resection for Squamous Cell Carcinoma of the Esophagus or Adenocarcinoma of the Cardia"],"prefix":"10.1245","volume":"16","author":[{"given":"Jun-Feng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glyn G.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tie-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Drew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,25]]},"reference":[{"key":"382_CR1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/bjs.1800840635","volume":"84","author":"H Li","year":"1997","unstructured":"Li H, Yao SC. Surgical treatment for carcinoma of the oesophagus in Chinese language publications. Br J Surg. 1997;84:855\u20137.","journal-title":"Br J Surg"},{"key":"382_CR2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/bjs.4402","volume":"91","author":"JF Liu","year":"2004","unstructured":"Liu JF, Wang QZ, Hou J. Surgical treatment for cancer of the oesophagus and gastric cardia in Hebei, China. Br J Surg. 2004;91:90\u20138.","journal-title":"Br J Surg"},{"key":"382_CR3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","volume":"6","author":"DH Burmeister","year":"2005","unstructured":"Burmeister DH, Smithers BM, MStat VG, Fitzgerald L, Simes RJ, Devitt P, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005;6:659\u201368.","journal-title":"Lancet Oncol"},{"key":"382_CR4","first-page":"375","volume":"4","author":"P Das","year":"2006","unstructured":"Das P, Fukami N, Ajani JA. Combined modality therapy of localized gastric and esophageal cancers. JNCCN. 2006;4:375\u201382.","journal-title":"JNCCN"},{"key":"382_CR5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","volume":"8","author":"V Gebski","year":"2007","unstructured":"Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226\u201334.","journal-title":"Lancet Oncol"},{"key":"382_CR6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1445-2197.2005.03596.x","volume":"75","author":"JF Liu","year":"2005","unstructured":"Liu JF, Jamieson GG, Drew PA, Zhu GJ, Zhang SW, Zhu TN, et al. Aspirin induces apoptosis in oesophageal cancer cells by inhibiting the pathway of NF-kappa B downstream regulation of cyclooxygenase-2. ANZ J Surg. 2005;75:1011\u20136.","journal-title":"ANZ J Surg"},{"key":"382_CR7","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ijc.23288","volume":"122","author":"JF Liu","year":"2008","unstructured":"Liu JF, Zhang SW, Jamieson GG, Zhu GJ, Wu TC, Zhu TN, et al. The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo. Int J Cancer. 2008;122:1639\u201344.","journal-title":"Int J Cancer"},{"key":"382_CR8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1442-2050.2006.00594.x","volume":"19","author":"JF Liu","year":"2006","unstructured":"Liu JF, Jamieson GG, Wu TC, Zhang SW, Wang QZ, Drew PA. Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus. Dis Esoph. 2006;19:350\u20134.","journal-title":"Dis Esoph"},{"key":"382_CR9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ijc.1322","volume":"93","author":"M Li","year":"2001","unstructured":"Li M, Wu X, Xu XC. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells. Int J Cancer. 2001;93:218\u201323.","journal-title":"Int J Cancer"},{"key":"382_CR10","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","volume":"320","author":"MJ Langman","year":"2000","unstructured":"Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ. 2000;320:1642\u20136.","journal-title":"BMJ"},{"key":"382_CR11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I","volume":"76","author":"EM Funkhouser","year":"1995","unstructured":"Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer. 1995;76:1116\u20139.","journal-title":"Cancer"},{"key":"382_CR12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/pmed.1995.1021","volume":"24","author":"MJ Thun","year":"1995","unstructured":"Thun MJ, Heath CW. Aspirin use and reduced risk of gastrointestinal tract cancers in the American Cancer Society prospective studies. Prev Med. 1995;24:116\u20138.","journal-title":"Prev Med"},{"key":"382_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01658071","volume":"12","author":"PA Barbier","year":"1988","unstructured":"Barbier PA, Becker CD, Wagner HE. Esophageal carcinoma: patient selection for transhiatal esophagectomy, A prospective analysis of 50 consecutive cases, World J Surg. 1988;12:263\u20139.","journal-title":"World J Surg"},{"key":"382_CR14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0748-7983(03)00098-2","volume":"29","author":"G Manzoni De","year":"2003","unstructured":"De Manzoni G, Pedrazzani C, Pasini F, Durante E, Gabbani M, Grandinetti A, et al. Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction. EJSO. 2003;29:506\u201310.","journal-title":"EJSO"},{"key":"382_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jamcollsurg.2003.10.005","volume":"198","author":"S Nakagawa","year":"2004","unstructured":"Nakagawa S, Kanda T, Kosugi SI, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205\u201311.","journal-title":"J Am Coll Surg"},{"key":"382_CR16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1442-2050.2006.00615.x","volume":"19","author":"S Natsugoe","year":"2006","unstructured":"Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Yokomakura N, et al. Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esoph. 2006;19:468\u201372.","journal-title":"Dis Esoph"},{"key":"382_CR17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1741-7015-2-35","volume":"2","author":"RA Malthaner","year":"2004","unstructured":"Malthaner RA, Wong RK, Rumble RB, Zuraw L;Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario\u2019s Program in Evidence-based Care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med. 2004;2:35\u201351.","journal-title":"BMC Med"},{"key":"382_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-146-5-200703060-00009","volume":"146","author":"C Dub\u00e9","year":"2007","unstructured":"Dub\u00e9 C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, Code C, et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med. 2007;146:365\u201375.","journal-title":"Ann Intern Med"},{"key":"382_CR19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1349-7006.2004.tb03165.x","volume":"95","author":"M Futakuchi","year":"2004","unstructured":"Futakuchi M, Ogawa K, Tamano S, Takahashi S, Shirai T. Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma. Cancer Sci. 2004;95:18\u201324.","journal-title":"Cancer Sci"},{"key":"382_CR20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jtcvs.2005.10.060","volume":"132","author":"LM Backhus","year":"2006","unstructured":"Backhus LM, Sievers E, Lin GY, Castanos R, Bart RD, Starnes VA, et al. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2006;132:297\u2013303.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"382_CR21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.athoracsur.2005.03.067","volume":"80","author":"SS Qadri","year":"2005","unstructured":"Qadri SS, Wang JH, Coffey JC, Alam M, O\u2019Donnell A, Aherne T, et al. Can surgery for cancer accelerate the progression of secondary tumors within residual minimal disease at both local and systemic levels? Ann Thorac Surg. 2005;80:1046\u201350.","journal-title":"Ann Thorac Surg"},{"key":"382_CR22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.phrs.2004.04.002","volume":"50","author":"WM Awara","year":"2004","unstructured":"Awara WM, El-Sisi AE, El-Sayad ME, Goda AE. The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumor: does celecoxib enhance the anti-tumor activity of doxorubicin? Pharmacol Res. 2004;50:487\u201398.","journal-title":"Pharmacol Res"},{"key":"382_CR23","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0959-8049(98)00045-8","volume":"34","author":"CP Duffy","year":"1998","unstructured":"Duffy CP, Elliott CJ, O\u2019Connor RA, Heenan MM, Coyle S, Cleary IM, et al. Enhancement of chemotherapeutic drug toxicity to human tumor cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs). Eur J Cancer. 1998;34:1250\u20139.","journal-title":"Eur J Cancer"},{"key":"382_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1620\/tjem.181.361","volume":"181","author":"S Kobayashi","year":"1997","unstructured":"Kobayashi S, Okada S, Yoshida H, Fujimura S. Indomethacin enhances the cytotoxicity of VCR and ADR in human pulmonary adenocarcinoma cells. Tohoku J Exp Med. 1997;181:361\u201370.","journal-title":"Tohoku J Exp Med"},{"key":"382_CR25","first-page":"775","volume":"18","author":"T Hida","year":"1998","unstructured":"Hida T, Leyton J, Makheja AN, Ben-Av P, Hla T, Martinez A, et al. Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs. Anticancer Res. 1998;18:775\u201382.","journal-title":"Anticancer Res"},{"key":"382_CR26","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/S0022-5347(05)64237-1","volume":"168","author":"Y Mizutani","year":"2002","unstructured":"Mizutani Y, Kamoi K, Ukimura O, Kawauchi A, Miki T. Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer. J Urol. 2002;168:2650\u20134.","journal-title":"J Urol"},{"key":"382_CR27","first-page":"2513","volume":"6","author":"C Petersen","year":"2000","unstructured":"Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Clin Cancer Res. 2000;6:2513\u201320.","journal-title":"Clin Cancer Res"},{"key":"382_CR28","first-page":"2998","volume":"7","author":"H Pyo","year":"2001","unstructured":"Pyo H, Choy H, Amorino GP, Kim JS, Cao Q, Hercules SK, et al. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res. 2001;7:2998\u20133005.","journal-title":"Clin Cancer Res"},{"key":"382_CR29","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0360-3016(02)03023-7","volume":"54","author":"U Raju","year":"2002","unstructured":"Raju U, Nakata E, Yang P, Newman RA, Ang KK, Milas L. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations. Int J Radiat Oncol Biol Phys. 2002;54:886\u201394.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"382_CR30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199509073331001","volume":"333","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333:609\u201314.","journal-title":"N Engl J Med"},{"key":"382_CR31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/pmed.1995.1021","volume":"24","author":"MJ Thun","year":"1995","unstructured":"Thun MJ, Heath CW. Aspirin use and reduced risk of gastrointestinal tract cancers in the American Cancer Society prospective studies. Prev Med. 1995;24:116\u20138.","journal-title":"Prev Med"},{"key":"382_CR32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.bjc.6690651","volume":"81","author":"JP Collet","year":"1999","unstructured":"Collet JP, Sharpe C, Belzile E, Boivin JF, Hanley J, Abenhaim L. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer. 1999;81:62\u20138.","journal-title":"Br J Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0382-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-009-0382-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0382-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T21:38:08Z","timestamp":1710106688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-009-0382-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,25]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1245\/s10434-009-0382-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,25]]}}}